1. Home
  2. DSL vs ALVOW Comparison

DSL vs ALVOW Comparison

Compare DSL & ALVOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSL
  • ALVOW
  • Stock Information
  • Founded
  • DSL 2013
  • ALVOW 2013
  • Country
  • DSL United States
  • ALVOW Luxembourg
  • Employees
  • DSL N/A
  • ALVOW 999
  • Industry
  • DSL Trusts Except Educational Religious and Charitable
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DSL Finance
  • ALVOW Health Care
  • Exchange
  • DSL Nasdaq
  • ALVOW Nasdaq
  • Market Cap
  • DSL N/A
  • ALVOW N/A
  • IPO Year
  • DSL N/A
  • ALVOW N/A
  • Fundamental
  • Price
  • DSL $12.61
  • ALVOW $1.52
  • Analyst Decision
  • DSL
  • ALVOW
  • Analyst Count
  • DSL 0
  • ALVOW 0
  • Target Price
  • DSL N/A
  • ALVOW N/A
  • AVG Volume (30 Days)
  • DSL 362.5K
  • ALVOW 15.0K
  • Earning Date
  • DSL 01-01-0001
  • ALVOW 02-27-2025
  • Dividend Yield
  • DSL 10.54%
  • ALVOW N/A
  • EPS Growth
  • DSL N/A
  • ALVOW N/A
  • EPS
  • DSL N/A
  • ALVOW N/A
  • Revenue
  • DSL N/A
  • ALVOW $393,919,000.00
  • Revenue This Year
  • DSL N/A
  • ALVOW N/A
  • Revenue Next Year
  • DSL N/A
  • ALVOW N/A
  • P/E Ratio
  • DSL N/A
  • ALVOW N/A
  • Revenue Growth
  • DSL N/A
  • ALVOW 517.92
  • 52 Week Low
  • DSL $11.85
  • ALVOW $2.33
  • 52 Week High
  • DSL $13.24
  • ALVOW $2.33
  • Technical
  • Relative Strength Index (RSI)
  • DSL 35.83
  • ALVOW N/A
  • Support Level
  • DSL $12.50
  • ALVOW N/A
  • Resistance Level
  • DSL $12.60
  • ALVOW N/A
  • Average True Range (ATR)
  • DSL 0.07
  • ALVOW 0.00
  • MACD
  • DSL -0.01
  • ALVOW 0.00
  • Stochastic Oscillator
  • DSL 5.00
  • ALVOW 0.00

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: